Skip to content ↓

CAVS artist's presentations begin next week

Vito Acconci's Instant House is a self-erecting architectural unit consisting of flags, wood, cables and pulleys. Acconci will speak at MIT next week.
Caption:
Vito Acconci's Instant House is a self-erecting architectural unit consisting of flags, wood, cables and pulleys. Acconci will speak at MIT next week.
Credits:
Photo courtesy / Acconci Studios

Acconci Studio founder Vito Acconci, one of America's foremost conceptual artists, will give this year's first Center for Advanced Visual Studies (CAVS) artist's presentation on Tuesday, Oct. 4, at 6:30 p.m. in Room N52-390.

Acconci, who began as a poet in the early 1960s, started in the mid-1970s producing audio and video installations that turned exhibition spaces into community meeting places. More recently, he has been creating large-scale architectural projects.

Acconci's latest projects explore the difference between public and private space and seek to invent a new kind of architecture that is fluid, changeable and portable. At the CAVS, he and contributing members of Acconci Studio, a theoretical design and building workshop he formed in 1988, will talk about how they work and discuss several upcoming projects, in a rare appearance as a group.

Subsequent CAVS presentations this fall will be made by Canadian artist Christina Mackie (Oct. 25) and the Danish artists' group N55 (Nov. 15).

A version of this article appeared in MIT Tech Talk on September 28, 2005 (download PDF).

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story